Cong Xue

4.6k citations

162 papers · 3.1k indexed · h-index 28

Impact in

Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- HER2/EGFR in Cancer Research
Cancer Research top 5%

Papers in ⓘ

Oncology 48
- Lung Cancer Research Studies 15
- HER2/EGFR in Cancer Research 12
- Cancer Immunotherapy and Biomarkers 9
Cancer Research 16

Co-authors: Yuanyuan Zhao (27 shared papers)Yan Huang (20 shared papers)Weifeng Liu (11 shared papers)Roujun Peng (5 shared papers)Hongyun Zhao (13 shared papers)Zhongyu Yuan (12 shared papers)Shusen Wang (11 shared papers)Tao Qin (9 shared papers)
Journals: Journal of Clinical Oncology (6 papers)Chinese Journal of Cancer (5 papers)BMC Cancer (4 papers)Oncotarget (4 papers)Drug Design Development and Therapy (4 papers)
Partner nations: China United States Germany

In The Last Decade

Cong Xue

151 papers receiving 3.0k citations

Peers

Countries citing papers authored by Cong Xue

Since Specialization

Citations

This map shows the geographic impact of Cong Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Xue more than expected).

Fields of papers citing papers by Cong Xue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cong Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Xue. The network helps show where Cong Xue may publish in the future.

Co-authors

The 25 scholars most cited alongside Cong Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Cong Xue Line = papers co-authored together Cong Xue links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 162 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis OncoTargets and Therapy ·Zhongyu Yuan, Rongzhen Luo, Roujun Peng, Shusen Wang, Cong Xue	2014	161
2	High PD-L1 expression was associated with poor prognosis in 870 Chinese patients with breast cancer Oncotarget ·Tao Qin, Yin-duo Zeng, Ge Qin, Fei Xu, Jia-Bin Lu, Wenfeng Fang, Cong Xue, Jian-hua Zhan, Xin-Ke Zhang, Qiu-fan Zheng, Roujun Peng, Zhong-Yu Yuan, Li Zhang, Shu-Sen Wang	2015	153
3	Kesterite Cu₂ZnSnS₄ as a Low-Cost Inorganic Hole-Transporting Material for High-Efficiency Perovskite Solar Cells ACS Applied Materials & Interfaces ·Qiliang Wu, Cong Xue, Yi Li, Pengcheng Zhou, Weifeng Liu, Jun Zhu, Songyuan Dai, Changfei Zhu, Shangfeng Yang	2015	152
4	The Role of Defects in Metal–Organic Frameworks for Nitrogen Reduction Reaction: When Defects Switch to Features Advanced Functional Materials ·Islam E. Khalil, Cong Xue, Wenjing Liu, Xiaohan Li, Yu Shen, Sheng Li, Weina Zhang, Fengwei Huo	2021	147
5	Performance and mechanisms of emerging animal-derived biochars for immobilization of heavy metals The Science of The Total Environment ·Sicong Lei, Yan Shi, Yuping Qiu, Lei Che, Cong Xue	2018	121
6	Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations PLoS ONE ·Wenhua Liang, Xuan Wu, Wenfeng Fang, Yuanyuan Zhao, Yunpeng Yang, Zhihuang Hu, Cong Xue, Jing Zhang, Jianwei Zhang, Yuxiang Ma, Ting Zhou, Yue Yan, Xue Hou, Tao Qin, Xiao-Xiao Dinglin, Ying Tian, Pei-Yu Huang, Yan Huang, Hongyun Zhao, Li Zhang	2014	105
7	The prognostic nutritional index (PNI) predicts overall survival of small-cell lung cancer patients Tumor Biology ·Shaodong Hong, Ting Zhou, Wenfeng Fang, Cong Xue, Zhihuang Hu, Tao Qin, Yanna Tang, Yue Chen, Yuxiang Ma, Yunpeng Yang, Xue Hou, Yan Huang, Hongyun Zhao, Yuanyuan Zhao, Li Zhang	2014	104
8	Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma Medical Oncology ·Jianwei Zhang, Wenfeng Fang, Tao Qin, Yunpeng Yang, Shaodong Hong, Wenhua Liang, Yuxiang Ma, Hongyun Zhao, Yan Huang, Cong Xue, Pei‐Yu Huang, Zhihuang Hu, Yuanyuan Zhao, Li Zhang	2015	104
9	National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China Lung Cancer ·Cong Xue, Zhihuang Hu, Wei Jiang, Yuanyuan Zhao, Fei Xu, Yan Huang, Hongyun Zhao, Jingxun Wu, Yang Zhang, Liping Zhao, Jing Zhang, Likun Chen, Li Zhang	2012	91
10	Immune-checkpoint inhibitor plus chemotherapy versus conventional chemotherapy for first-line treatment in advanced non-small cell lung carcinoma: a systematic review and meta-analysis Journal for ImmunoTherapy of Cancer ·Yixin Zhou, Chen Chen, Xuanye Zhang, Sha Fu, Cong Xue, Yuxiang Ma, Wenfeng Fang, Yunpeng Yang, Xue Hou, Yan Huang, Hongyun Zhao, Shaodong Hong, Li Zhang	2018	82
11	Cu2SnS3 solar cells fabricated by chemical bath deposition–annealing of SnS/Cu stacked layers Solar Energy Materials and Solar Cells ·Jianmin Li, Cong Xue, Yaguang Wang, Guoshun Jiang, Weifeng Liu, Changfei Zhu	2015	65
12	PD-L1 is remarkably over-expressed in EBV-associated pulmonary lymphoepithelioma-like carcinoma and related to poor disease-free survival Oncotarget ·Wenfeng Fang, Shaodong Hong, Nan Chen, Xiaobo He, Jianhua Zhan, Tao Qin, Ting Zhou, Zhihuang Hu, Yuxiang Ma, Yuanyuan Zhao, Ying Tian, Yunpeng Yang, Cong Xue, Yanna Tang, Yan Huang, Hongyun Zhao, Li Zhang	2015	61
13	Rational Synthesis and Regulation of Hollow Structural Materials for Electrocatalytic Nitrogen Reduction Reaction Advanced Science ·Cong Xue, Xinru Zhou, Xiaohan Li, Nan Yang, Xin Xue, Yusheng Wang, Weina Zhang, Jiansheng Wu, Wenjing Liu, Fengwei Huo	2021	54
14	Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China Cancer Science ·Cong Xue, Xi Wang, Roujun Peng, Yanxia Shi, Tao Qin, Donggen Liu, Xiaoyu Teng, Shusen Wang, Li Zhang, Zhongyu Yuan	2012	53
15	Maleimides in Directing‐Group‐Controlled Transition‐Metal‐Catalyzed Selective C−H Alkylation European Journal of Organic Chemistry ·Shuang‐Liang Liu, Yajun Shi, Cong Xue, Liming Zhang, Liming Zhou, Mao‐Ping Song	2021	48
16	Comparison of different methods for detecting epidermal growth factor receptor mutations in peripheral blood and tumor tissue of non-small cell lung cancer as a predictor of response to gefitinib OncoTargets and Therapy ·Li Zhang, Fei Xu, Jingxun Wu, Cong Xue, Yuanyuan Zhao, Wei Jiang, Liping Lin, Xuan Wu, Yachao Lu, Hua Bai, Jiasen Xu, Guanshan Zhu	2012	45
17	Predictive Value of Intratumoral Microvascular Density in Patients with Advanced Non-small Cell Lung Cancer Receiving Chemotherapy Plus Bevacizumab Journal of Thoracic Oncology ·Yuanyuan Zhao, Cong Xue, Wei Jiang, Hong-Yun Zhao, Yan Huang, Kristin Feenstra, James H. Resau, Chao-Nan Qian, Zhang Li	2011	44
18	Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo Drug Design Development and Therapy ·Yuanyuan Zhao, Ying Tian, Jing Zhang, Fei Xu, Yun-Peng Yang, Yan Huang, Hong-Yun Zhao, Jianwei Zhang, Cong Xue, Michael Hon‐Wah Lam, Yan Li, Zhi-Huang Hu, Xiao-Xiao Dinglin, Li Zhang	2014	42
19	The relationship between drug exposure and clinical outcomes of non-small cell lung cancer patients treated with gefitinib Medical Oncology ·Yuanyuan Zhao, Li Su, Yang Zhang, Hong-Yun Zhao, Hai Liao, Ying Guo, Yan-Xia Shi, Wei Jiang, Cong Xue, Li Zhang	2010	41
20	SPARC expression and prognostic value in non-small cell lung cancer Chinese Journal of Cancer ·Yan Huang, Jing Zhang, Yuanyuan Zhao, Wei Jiang, Cong Xue, Fei Xu, Hong-Yun Zhao, Yang Zhang, Li-Ping Zhao, Zhi-Huang Hu, Zhi-Wen Yao, Qian-Yong Liu, Li Zhang	2012	41

About Cong Xue

Cong Xue is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Structural Biology and Animal Science and Zoology, having authored 162 papers that have together received 3.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Lung Cancer Research Studies (15 papers), HER2/EGFR in Cancer Research (12 papers), Chalcogenide Semiconductor Thin Films (12 papers), Quantum Dots Synthesis And Properties (10 papers), Cancer Immunotherapy and Biomarkers (9 papers), Copper-based nanomaterials and applications (9 papers) and Virology and Viral Diseases (9 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (379 citations), Pulmonary and Respiratory Medicine (623 citations), Catalysis (119 citations) and Immunology (319 citations). Cong Xue has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yuanyuan Zhao, Yan Huang, Weifeng Liu, Roujun Peng, Hongyun Zhao, Zhongyu Yuan, Shusen Wang, Tao Qin, Wenfeng Fang and Yuxiang Ma. Their work appears in journals such as Journal of Clinical Oncology, Chinese Journal of Cancer, BMC Cancer, Oncotarget and Drug Design Development and Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact